{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:29:15Z","timestamp":1792704555649,"version":"4.5.0"},"reference-count":68,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,2,9]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Contrasting patterns of basal phosphorylation levels and \u03b1-BCR\u2013induced signaling between CLL and MCL tumors. Direct association between BCR-induced signaling strength and CD79B level, but inverse association with BTK and SYK inhibitor efficacy.<\/jats:p>","DOI":"10.1182\/blood-2016-05-718494","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T22:00:30Z","timestamp":1482530430000},"page":"759-770","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":78,"title":["Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling"],"prefix":"10.1182","volume":"129","author":[{"given":"June H.","family":"Myklebust","sequence":"first","affiliation":[{"name":"Oncology Division, Department of Medicine, Stanford University, Stanford, CA;"},{"name":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway;"},{"name":"Center for Cancer Biomedicine, University of Oslo, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Brody","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Medicine, Stanford University, Stanford, CA;"},{"name":"Lymphoma Immunotherapy Program, Mount Sinai School of Medicine, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holbrook E.","family":"Kohrt","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Medicine, Stanford University, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Kolstad","sequence":"additional","affiliation":[{"name":"Cancer Clinic, Department of Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra K.","family":"Czerwinski","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Medicine, Stanford University, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"W\u00e4lchli","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway;"},{"name":"Center for Cancer Biomedicine, University of Oslo, Oslo, Norway;"},{"name":"Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Green","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Medicine, Stanford University, Stanford, CA;"},{"name":"Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild","family":"Tr\u00f8en","sequence":"additional","affiliation":[{"name":"Cancer Clinic, Department of Pathology, Oslo University Hospital, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Liest\u00f8l","sequence":"additional","affiliation":[{"name":"Center for Cancer Biomedicine, University of Oslo, Oslo, Norway;"},{"name":"Department of Informatics, University of Oslo, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Beiske","sequence":"additional","affiliation":[{"name":"Cancer Clinic, Department of Pathology, Oslo University Hospital, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roch","family":"Houot","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie Clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France;"},{"name":"INSERM U917, Universit\u00e9 de Rennes, Rennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Delabie","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ash A.","family":"Alizadeh","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Medicine, Stanford University, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Irish","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Medicine, Stanford University, Stanford, CA;"},{"name":"Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Levy","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Medicine, Stanford University, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111903440622400_B1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal centres: role in B-cell physiology and malignancy","volume":"8","author":"Klein","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2019111903440622400_B2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nri953","article-title":"Lymphoid malignancies: the dark side of B-cell differentiation","volume":"2","author":"Shaffer","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2019111903440622400_B3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"6-7","key":"2019111903440622400_B4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molimm.2004.04.008","article-title":"B cell antigen receptor signaling 101","volume":"41","author":"Dal Porto","year":"2004","journal-title":"Mol Immunol"},{"issue":"1","key":"2019111903440622400_B5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-immunol-030409-101216","article-title":"Early events in B cell activation","volume":"28","author":"Harwood","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"2019111903440622400_B6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2004.05.014","article-title":"Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha\/beta heterodimer","volume":"117","author":"Kraus","year":"2004","journal-title":"Cell"},{"issue":"6","key":"2019111903440622400_B7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","article-title":"In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Lam","year":"1997","journal-title":"Cell"},{"issue":"4","key":"2019111903440622400_B8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri1808","article-title":"ITAM-mediated tonic signalling through pre-BCR and BCR complexes","volume":"6","author":"Monroe","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2019111903440622400_B9","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1073\/pnas.051626198","article-title":"BLNK mediates Syk-dependent Btk activation","volume":"98","author":"Baba","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019111903440622400_B10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bbamcr.2009.03.004","article-title":"Syk and pTyr\u2019d: signaling through the B cell antigen receptor","volume":"1793","author":"Geahlen","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2019111903440622400_B11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00748.x","article-title":"Tyrosine kinases and their substrates in B lymphocytes","volume":"228","author":"Kurosaki","year":"2009","journal-title":"Immunol Rev"},{"issue":"12","key":"2019111903440622400_B12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nri955","article-title":"Regulation of B-cell fate by antigen-receptor signals","volume":"2","author":"Niiro","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2019111903440622400_B13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-065X.2009.00836.x","article-title":"Comprehending the complex connection between PKCbeta, TAK1, and IKK in BCR signaling","volume":"232","author":"Shinohara","year":"2009","journal-title":"Immunol Rev"},{"issue":"3","key":"2019111903440622400_B14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrd3937","article-title":"Targeting pathological B cell receptor signalling in lymphoid malignancies","volume":"12","author":"Young","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"7415","key":"2019111903440622400_B15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"D\u00fchren-von Minden","year":"2012","journal-title":"Nature"},{"issue":"7","key":"2019111903440622400_B16","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/leu.2015.39","article-title":"Chlamydophila psittaci-negative ocular adnexal marginal zone lymphomas express self polyreactive B-cell receptors","volume":"29","author":"Zhu","year":"2015","journal-title":"Leukemia"},{"issue":"9","key":"2019111903440622400_B17","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.4049\/jimmunol.1300179","article-title":"Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen","volume":"190","author":"Cha","year":"2013","journal-title":"J Immunol"},{"issue":"43","key":"2019111903440622400_B18","doi-asserted-by":"crossref","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"2019111903440622400_B19","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2012-05-427534","article-title":"Self-antigen recognition by follicular lymphoma B-cell receptors","volume":"120","author":"Sachen","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2019111903440622400_B20","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.4049\/jimmunol.1402341","article-title":"Primary central nervous system (CNS) lymphoma B cell receptors recognize CNS proteins","volume":"195","author":"Montesinos-Rongen","year":"2015","journal-title":"J Immunol"},{"issue":"44","key":"2019111903440622400_B21","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1073\/pnas.1514944112","article-title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","volume":"112","author":"Young","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7247","key":"2019111903440622400_B22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"issue":"7277","key":"2019111903440622400_B23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"5870","key":"2019111903440622400_B24","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"issue":"1","key":"2019111903440622400_B25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1200\/JCO.2012.42.7906","article-title":"Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies","volume":"31","author":"Advani","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111903440622400_B26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1400376","article-title":"Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia","volume":"371","author":"Byrd","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111903440622400_B27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111903440622400_B28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111903440622400_B29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2014-08-597914","article-title":"A phase 1\/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed\/refractory non-Hodgkin lymphoma","volume":"125","author":"Maddocks","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2019111903440622400_B30","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bjh.12073","article-title":"Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma\/chronic lymphocytic leukaemia and marginal zone lymphoma patients","volume":"159","author":"Blix","year":"2012","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111903440622400_B31","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood-2006-02-003921","article-title":"Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells","volume":"108","author":"Irish","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111903440622400_B32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2004.06.028","article-title":"Single cell profiling of potentiated phospho-protein networks in cancer cells","volume":"118","author":"Irish","year":"2004","journal-title":"Cell"},{"issue":"29","key":"2019111903440622400_B33","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1073\/pnas.1002057107","article-title":"B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression","volume":"107","author":"Irish","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019111903440622400_B34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2012-04-421826","article-title":"High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells","volume":"121","author":"Myklebust","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2019111903440622400_B35","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.4049\/jimmunol.177.3.1581","article-title":"Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry","volume":"177","author":"Irish","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"2019111903440622400_B36","doi-asserted-by":"crossref","first-page":"e46117","DOI":"10.1371\/journal.pone.0046117","article-title":"Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma","volume":"7","author":"Huse","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"2019111903440622400_B37","doi-asserted-by":"crossref","first-page":"e27930","DOI":"10.1371\/journal.pone.0027930","article-title":"A practical approach to T-cell receptor cloning and expression","volume":"6","author":"W\u00e4lchli","year":"2011","journal-title":"PLoS One"},{"issue":"17","key":"2019111903440622400_B38","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Choi","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2019111903440622400_B39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2019111903440622400_B40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","article-title":"Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia","volume":"101","author":"Lanham","year":"2003","journal-title":"Blood"},{"issue":"10","key":"2019111903440622400_B41","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","article-title":"Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status","volume":"109","author":"Mockridge","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2019111903440622400_B42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood-2007-12-127688","article-title":"BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells","volume":"112","author":"Guarini","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111903440622400_B43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"issue":"6769","key":"2019111903440622400_B44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"9","key":"2019111903440622400_B45","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"16","key":"2019111903440622400_B46","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","article-title":"B-cell receptor signaling in chronic lymphocytic leukemia","volume":"118","author":"Stevenson","year":"2011","journal-title":"Blood"},{"issue":"6260","key":"2019111903440622400_B47","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/343760a0","article-title":"Molecular components of the B-cell antigen receptor complex of the IgM class","volume":"343","author":"Hombach","year":"1990","journal-title":"Nature"},{"issue":"3","key":"2019111903440622400_B48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bbrc.2014.02.037","article-title":"IgG1 cytoplasmic tail is essential for cell surface expression in Ig\u03b2 down-regulated cells","volume":"445","author":"Todo","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"5260","key":"2019111903440622400_B49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1126\/science.272.5260.411","article-title":"Regulation of an early developmental checkpoint in the B cell pathway by Ig beta","volume":"272","author":"Gong","year":"1996","journal-title":"Science"},{"issue":"45","key":"2019111903440622400_B50","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Be\u00e0","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"2019111903440622400_B51","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2013-07-517177","article-title":"The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells","volume":"123","author":"Zhang","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2019111903440622400_B52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.V90.4.1387.1387_1387_1394","article-title":"Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia","volume":"90","author":"Thompson","year":"1997","journal-title":"Blood"},{"issue":"7574","key":"2019111903440622400_B53","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"1","key":"2019111903440622400_B54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat Genet"},{"issue":"5","key":"2019111903440622400_B55","first-page":"413","article-title":"Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders","volume":"84","author":"Cabezudo","year":"1999","journal-title":"Haematologica"},{"issue":"11","key":"2019111903440622400_B56","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1182\/blood.V99.11.4087","article-title":"B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes","volume":"99","author":"Damle","year":"2002","journal-title":"Blood"},{"issue":"24","key":"2019111903440622400_B57","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1182\/blood-2015-11-682906","article-title":"IL-4 enhances expression and function of surface IgM in CLL cells","volume":"127","author":"Aguilar-Hernandez","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2019111903440622400_B58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2015-11-682997","article-title":"IL-4 rescues surface IgM expression in chronic lymphocytic leukemia","volume":"128","author":"Guo","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2019111903440622400_B59","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S1470-2045(15)70128-2","article-title":"Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study","volume":"16","author":"Palanca-Wessels","year":"2015","journal-title":"Lancet Oncol"},{"issue":"14","key":"2019111903440622400_B60","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2013-02-482125","article-title":"Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients","volume":"122","author":"Chang","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2019111903440622400_B61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood-2015-11-681460","article-title":"Pathogenic role of B-cell receptor signaling and canonical NF-\u03baB activation in mantle cell lymphoma","volume":"128","author":"Saba","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2019111903440622400_B62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc3702","article-title":"Targeting Bruton\u2019s tyrosine kinase in B cell malignancies","volume":"14","author":"Hendriks","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"2019111903440622400_B63","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2013.53.1046","article-title":"Bruton\u2019s tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies","volume":"32","author":"Ponader","year":"2014","journal-title":"J Clin Oncol"},{"issue":"15","key":"2019111903440622400_B64","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2013-06-507947","article-title":"Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes","volume":"122","author":"Dubovsky","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2019111903440622400_B65","doi-asserted-by":"crossref","first-page":"E966","DOI":"10.1073\/pnas.1500712112","article-title":"Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK","volume":"112","author":"Sagiv-Barfi","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111903440622400_B66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ymeth.2015.05.008","article-title":"Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data","volume":"82","author":"Diggins","year":"2015","journal-title":"Methods"},{"issue":"12","key":"2019111903440622400_B67","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ni.3034","article-title":"Beyond the age of cellular discovery","volume":"15","author":"Irish","year":"2014","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111903440622400_B68","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/6\/759\/1401794\/blood718494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/6\/759\/1401794\/blood718494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T07:26:57Z","timestamp":1718954817000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/6\/759\/36328\/Distinct-patterns-of-Bcell-receptor-signaling-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,9]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-05-718494","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,9]]}}}